| PERIOD ENDING | 30-Jun-08 | 31-Mar-08 | 31-Dec-07 | 30-Sep-07 | | Total Revenue | 2,503,000 | 3,270,000 | 3,110,000 | 2,663,000 | | Cost of Revenue | 1,534,000 | 1,943,000 | 1,473,000 | 1,160,000 | | | Gross Profit | 969,000 | 1,327,000 | 1,637,000 | 1,503,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 625,000 | 781,000 | 963,000 | 761,000 | | Non Recurring | (114,000) |
-
| 3,000 | 69,000 | | Others | 171,000 | 175,000 | 172,000 | 174,000 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 287,000 | 371,000 | 499,000 | 499,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 36,000 | 39,000 | 16,000 | 28,000 | | Earnings Before Interest And Taxes | 466,000 | 408,000 | 514,000 | 526,000 | | Interest Expense | 38,000 | 60,000 | 56,000 | 80,000 | | Income Before Tax | 428,000 | 348,000 | 458,000 | 446,000 | | Income Tax Expense | 202,000 | 127,000 | 183,000 | 135,000 | | Minority Interest | (3,000) | (2,000) | (3,000) | (2,000) | | | | Net Income From Continuing Ops | 244,000 | 242,000 | 288,000 | 330,000 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
| 1,000 | (25,000) | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 244,000 | 242,000 | 289,000 | 305,000 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $244,000 | $242,000 | $289,000 | $305,000 |
|
5.11% Nasdaq 
Income Statement
